Special Issue "Advanced Nanosystems for Ophthalmic Administration"
A special issue of Nanomaterials (ISSN 2079-4991).
Deadline for manuscript submissions: closed (30 September 2019).
Interests: formulation of drug delivery systems for systemic or topical administration; development of nano/micro-systems: microemulsions, emulsions, liposomes, lipid nanoparticles; thermosensitive drug delivery systems; inorganic nanoparticles: mesoporous silica nanoparticles, nanotitania; Calcium phosphate coatings; skin delivery of antioxidants; advanced nanosystems for intraocular administrations: nanocomposites, thermosensitive hydrogels, in vitro ocular flow models
Special Issues and Collections in MDPI journals
Ophthalmic therapies have recently been improved by the introduction of novel drug delivery approaches using implants or devices, advanced biomaterials, nanomedicines, stimuli-responsive systems, cell therapy, etc. These technologies are applied for the treatment of several anterior/posterior-segment diseases such as dry eye, allergy, inflammations, infections, glaucoma, cataract and retinal disorders (age-related macular degeneration, diabetic retinopathy, and others). Most of the inserts/implants are invasively applied and require surgical procedures, and advanced drug delivery systems (DDSs) based on nanotechnologies appear to provide more effective non-invasive therapies even though they require increasing efforts to obtain high clinical impacts. The employment of in vitro models to estimate the ocular drug release residence time and clearance plays an important role in this research progress. This Special Issue of Nanomaterials will survey the challenges and the current state-of-the-art in the use of nanomaterials to create advanced DDSs for the treatment of ocular diseases.
Dr. Simona Sapino
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Ocular diseases
- Intraocular drug delivery
- Ocular barriers
- Ophthalmic implants
- Stimuli-responsive systems
- In vitro ocular models
- Cell cultures